BIOCRYST PHARMACEUTICALS's ticker is and the CUSIP is 09058V903. A total of 4 filers reported holding BIOCRYST PHARMACEUTICALS in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,387 | -97.3% | 295,000 | +742.9% | 0.00% | – |
| Q2 2019 | $127,000 | -82.5% | 35,000 | -61.1% | 0.00% | – |
| Q4 2018 | $726,000 | +1.8% | 90,000 | -3.7% | 0.00% | – |
| Q3 2018 | $713,000 | -18.5% | 93,500 | -10.3% | 0.00% | – |
| Q1 2017 | $875,000 | +3140.7% | 104,200 | +2381.0% | 0.00% | – |
| Q4 2016 | $27,000 | – | 4,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 24,600 | $241,000 | 0.00% |
| Citadel Advisors | 32,400 | $317,000 | 0.00% |